T-SCAPE demonstrates superior prediction of T cell activation and therapeutic antibody potential, highlighting deep learning's role in vaccine development.
T cell immunogenicity, the ability of peptide fragments to elicit T cell responses, is a critical determinant of the safety and efficacy of protein therapeutics and vaccines. While deep learning shows promise for in silico prediction, the scarcity of comprehensive immunogenicity data is a major challenge. We present T cell immunogenicity scoring via cross-domain aided predictive engine (T-SCAPE), a novel multidomain deep learning framework that leverages adversarial domain adaptation to integrate diverse immunologically relevant data sources, including major histocompatibility complex (MHC) presentation, peptide-MHC (pMHC) binding affinity, T cell receptor–pMHC interaction, source organism information, and T cell activation. Validated through rigorous leakage-controlled benchmarks, T-SCAPE demonstrates exceptional performance in predicting T cell activation for specific peptide-MHC pairs. It also accurately predicts the antidrug antibody–inducing potential of therapeutic antibodies without requiring MHC inputs. This success is attributed to T-SCAPE’s biologically grounded and data-driven multidomain pretraining. Its consistent and robust performance highlights its potential to advance the development of safer and more effective vaccines and protein therapeutics.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: